2009
DOI: 10.2340/00015555-0634
|View full text |Cite
|
Sign up to set email alerts
|

Downregulation of SMAD2, 4 and 6 mRNA and TGFβ Receptor I mRNA in Lesional and Non-lesional Psoriatic Skin

Abstract: Transforming growth factor beta (TGFbeta) has been suggested to be an effective inhibitor of the increased keratinocyte proliferation in psoriasis. Three TGFbeta isoforms are described (TGFbeta1, 2 and 3), signalling via a heteromeric receptor complex of TGFbetaRI and TGFbetaRII. Receptor binding activates SMAD2, 3 and 4, which translocate into the nucleus and regulate TGFbeta-responsive genes. SMAD6 and 7 proteins represent a negative feedback loop inhibiting the TGFbeta-SMAD signalling path-way. As TGFbeta1 … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
15
1

Year Published

2011
2011
2019
2019

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 19 publications
(16 citation statements)
references
References 25 publications
(26 reference statements)
0
15
1
Order By: Relevance
“…We also M Jiang et al observed lower phosphorylation of SMAD2/3 in psoriatic epidermis compared with healthy controls. Yu et al (2009) showed that the mRNA levels of SMAD2, 4, and 6 were downregulated in lesional and nonlesional psoriatic skin, whereas our data found no significant change in the mRNA levels of SMAD2, 4, 6, and 7 in psoriatic epidermis compared with healthy controls. This discrepancy may be due to samples from psoriatic patients being from different stages and severities.…”
Section: Discussioncontrasting
confidence: 82%
“…We also M Jiang et al observed lower phosphorylation of SMAD2/3 in psoriatic epidermis compared with healthy controls. Yu et al (2009) showed that the mRNA levels of SMAD2, 4, and 6 were downregulated in lesional and nonlesional psoriatic skin, whereas our data found no significant change in the mRNA levels of SMAD2, 4, 6, and 7 in psoriatic epidermis compared with healthy controls. This discrepancy may be due to samples from psoriatic patients being from different stages and severities.…”
Section: Discussioncontrasting
confidence: 82%
“…4). For example, Smad6 was associated with keratinocytes15; Myod1, with alveolar rhabdomyosarcoma16; and Hnf4a, with lipoproteins17.…”
Section: Resultsmentioning
confidence: 99%
“…Our results confirmed such Th1/Th17 cytokine profile in psoriatic sera, which is also consistent with the previous report . These cytokines regulate the expression of membrane receptors in keratinocytes , which may consequently alter the reaction of keratinocytes to stimuli signals. The enhancement effect of TWEAK on cell proliferation is seen at the combination with psoriatic cytokines (M5).…”
Section: Discussionmentioning
confidence: 99%